• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue private adhd medication cost medications during pregnancy and breastfeeding is a challenge for women suffering from the condition. There isn't much information on how long-term exposure to these drugs can affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus don't develop neurological developmental conditions like hearing or vision impairment seizures, febrile seizures or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication need to evaluate the benefits of using it against the potential risks for the baby. Doctors don't have enough data to provide clear recommendations however they can provide information on risks and benefits to aid pregnant women in making an informed decision.

A study published in Molecular Psychiatry found that women who were taking ADHD medications during early pregnancy did not have an increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers conducted a massive sample-based case control study to examine the prevalence of structural defects that were major in infants born to mothers who took stimulants during pregnancy. Pediatric cardiologists and clinical geneticists examined the cases to ensure correct classification of the cases and to reduce the possibility of bias.

The study of the researchers had some limitations. Most important, they were unable to distinguish the effects of the medication from those of the disorder at hand. This limitation makes it difficult for researchers to establish whether the few associations observed between the groups exposed were due to the use of medications or confounded by co-morbidities. Additionally the study did not look at long-term offspring outcomes.

The study did reveal that babies whose mothers had taken ADHD medication during pregnancy were at a more risk of being admitted to the neonatal intensive care unit (NICU) than those who whose mothers did not take any medication or had taken off their medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not influenced by the stimulant medication used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher likelihood of having to have an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These increases appear to be unrelated to the type of medication used during pregnancy.

Researchers suggest that the minor risk of using ADHD medications in early pregnancies could be offset by the greater benefits to both mother and baby from continuing treatment for the woman's condition. Physicians should speak with their patients about this issue and try to help them develop coping skills that can lessen the impact of her disorder in her daily life and relationships.

Medication Interactions

Doctors are increasingly confronted with the dilemma of whether to maintain treatment or stop as more women are diagnosed with ADHD. These decisions are frequently made without clear and reliable evidence. Instead, doctors have to take into account their own experience in conjunction with the experiences of other doctors, and the research that has been conducted on the subject.

In particular, the issue of possible risks to the infant can be difficult. Many of the studies on this topic are based on observational evidence instead of controlled research and their findings are often contradictory. The majority of studies restrict their analysis to live births, which can underestimate the teratogenic impact leading to terminations or abortions of pregnancy. The study that is discussed in the journal club addresses these shortcomings by analyzing data on live and deceased births.

The conclusion: While certain studies have demonstrated an association between ADHD medications and the possibility of certain birth defects, others have found no connection and the majority of studies show a neutral or even slightly negative effect. As a result an accurate risk-benefit analysis must be conducted in every instance.

It can be difficult, if not impossible, for women suffering from ADHD to stop taking their medication. In a recent piece published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping adhd medication and pregnancy Uk medications during pregnancy can you get adhd medication without a diagnosis uk lead to depression and feelings of isolation. A decrease in medication could also affect the ability to safely drive and perform work-related tasks, which are essential aspects of everyday life for those suffering from ADHD.

She suggests that women who are not sure whether to continue taking medication or stop it due to their pregnancy should educate family members, coworkers and friends about the condition, its impact on daily functioning and the advantages of staying on the current treatment regimen. Educating them can also aid in ensuring that the woman feels supported when she is struggling with her decision. Some medications can pass through the placenta. If a woman decides not to take her ADHD medication while pregnant and breastfeeding, it is important to be aware that the medication could be passed on to her baby.

Risk of Birth Defects

As the use and misuse of ADHD drugs to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD) increases the concern over the potential adverse effects of the drugs on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this subject. Researchers used two huge datasets to analyze over 4.3 million pregnant women and determine whether stimulant medications increased birth defects. Researchers discovered that, while the overall risk is low, first-trimester ADHD medication exposure was associated with slightly higher risk of certain heart defects, like ventriculoseptal defects.

The researchers of the study could not discover any link between early use of medication and other congenital anomalies such as facial deformities or club feet. The findings are in line with previous studies showing an increase, but not significant, in the risk of developing cardiac malformations in women who started taking ADHD medications prior to pregnancy. The risk increased in the latter half of pregnancy when a large number of women decided to stop taking their medication.

Women who took ADHD medications in the first trimester of their pregnancy were also more likely to experience caesarean sections, a low Apgar score following delivery, and a baby that required help breathing at birth. However, the authors of the study were not able to eliminate bias due to selection by limiting the study to women who didn't have other medical issues that could have contributed to these findings.

Researchers hope that their research will inform physicians when they see pregnant women. The researchers suggest that while discussing risks and benefits are important, the decision about whether to continue or stop taking medication should be based on the severity of each woman's ADHD symptoms and her needs.

The authors also caution that even though stopping the medication is an option, it is not an option that is recommended due to the high rate of depression and other mental health issues among women who are pregnant or who are recently postpartum. Further, the research suggests that women who choose to stop taking their medication are more likely to experience difficulties adapting to life without them after the birth of their baby.

Nursing

It can be a stressful experience becoming a mother. Women with ADHD who must work through their symptoms while attending physician appointments as well as getting ready for the arrival of their child and adjusting to new household routines can experience severe challenges. Many women choose to continue taking their ADHD medication during pregnancy.

The risk for nursing infant is low because the majority of stimulant medications is absorbed through breast milk in low amounts. However, the rate of medication exposure to the newborn may differ based on dosage, frequency it is administered, and at what time the medication is administered. In addition, various medications are introduced into the baby's system through the gastrointestinal tract or through breast milk. The effect on the health of a newborn is not fully known.

Some doctors may stop taking stimulant medications during a woman's pregnancy due to the lack of research. This is a difficult choice for the patient, who must balance the benefit of continuing her medication against the possible risks to the fetus. In the meantime, until more information is available, GPs may inquire about pregnant patients if they have any history of ADHD or if they intend to take medication in the perinatal period.

A growing number of studies have revealed that women can continue to take their ADHD medication during pregnancy and while breastfeeding. In response, an increasing number of patients are choosing to do so. They have concluded, in consultation with their physicians, that the benefits of retaining their current medication outweigh any possible risks.

It's important for women with ADHD who are thinking of breastfeeding to seek out a specialist psychiatrist's advice prior to becoming pregnant. They should discuss their medication with their prescriber and discuss the pros and cons for continuing treatment. This includes non medication treatment for adhd-pharmacological methods. Psychoeducation should also be offered to help pregnant people with ADHD be aware of their symptoms and the root cause, learn about available treatment options and strengthen existing coping strategies. This should be a multidisciplinary effort including obstetricians, GPs and psychiatry. Pregnancy counseling should include discussion of a treatment plan for the mother and child, as well as monitoring for signs of deterioration and, if necessary modifications to the medication regime.